1,134 karma · joined August 22, 2011
> Similar reductions in COVID-19-related hospitalization or death were observed in patients treated within five days of symptom onset; 1.0% of patients who received PAXLOVID™ were hospitalized through Day 28 following randomization (6/607 hospitalized, with no deaths), compared to 6.7% of patients who received a placebo (41/612 hospitalized with 10 subsequent deaths), with high statistical significance (p<0.0001). In the overall study population through Day 28, no deaths were reported in patients who received PAXLOVID™ as compared to 10 (1.6%) deaths in patients who received placebo.
Those extra two days (three versus five) could make a huge difference.
I shuddered reading that.
That's one of the least subtle things I've ever seen and I've been following some of this for a while.
That's a pretty major factor.
I'm having trouble seeing how you can look at that and claim well maybe it's not really white supremacy.